Key equity indices bounced back and were trading near day's high in early afternoon trade. At 12:21 IST, the barometer index, the S&P BSE Sensex, was up 74.13 points or 0.22% at 33965.26. The Nifty 50 index was up 41.55 points or 0.41% at 10,239.95. Recovery was backed by strength in IT and pharmaceutical shares. Trading sentiment was, however, fragile amid worsening relationship between the Reserve Bank of India and the government.
Among secondary barometers, the BSE Mid-Cap index was up 0.41%. The BSE Small-Cap index was up 0.57%. Both these indices outperformed the Sensex.
The market breadth, indicating the overall health of the market, turned positive from negative. On BSE, 1176 shares rose and 1048 shares fell. A total of 141 shares were unchanged.
IT stocks rose as the rupee weakened against the dollar. MindTree (up 6.28%), Hexaware Technologies (up 3.32%), MphasiS (up 3.32%), Infosys (up 3.13%), HCL Technologies (up 2.78%), Persistent Systems (up 2.77%), Oracle Financial Services Software (up 1.63%) and TCS (up 0.20%), edged higher. Wipro was down 0.94%.
A weak rupee boosts revenue of IT firms in rupee terms as the sector derives a lion's share of revenue from exports. The partially convertible rupee was hovering at 74.055, compared with its close of 73.68 during the previous trading session.
Tech Mahindra surged 7.13% after consolidated profit after tax rose 18.5% to Rs 1064 crore on 4.3% rise in revenue to Rs 8630 crore in Q2 September 2018 over Q1 June 2018. The result was announced after market hours yesterday, 30 October 2018.
Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) rose 19.3% to Rs 1619 crore in Q2 September 2018 over Q1 June 2018. The board of directors of Tech Mahindra considered and approved the proposal for merger by absorption of Tech Mahindra Growth Factories (TMGFL), a wholly owned subsidiary company with Tech Mahindra. The business of TMGFL was to create certain new business avenues including education and training services for corporate/working professionals & students.
Also Read
C P Gurnani, Managing Director & Chief Executive Officer, Tech Mahindra said that barring declines in implementation business in healthcare vertical, the company has clocked a good quarter in terms of both revenue growth and EBIDTA margin improvement.
Most pharmaceutical shares rose. Wockhardt (up 3.79%), IPCA Laboratories (up 3.72%), Cadila Healthcare (up 2.38%), Glenmark Pharmaceuticals (up 2.09%), Aurobindo Pharma (up 2.03%), Piramal Enterprises (up 1.94%), Sun Pharmaceutical Industries (up 1.77%), Strides Shasun (up 1.09%), Cipla (up 1.05%), Divi's Laboratories (up 0.99%) and Lupin (up 0.87%), edged higher. Alkem Laboratories (down 0.21%) and GlaxoSmithKline Pharmaceuticals (down 0.24%), edged lower.
Dr Reddy's Laboratories was down 2.38%. The company said that the audit of formulations manufacturing facility at Duvvada, Visakhapatnam, by the USFDA, has been completed. The company received Form-483 with eight observations which it is addressing, Dr. Reddy's Laboratories said. The announcement was made after market hours yesterday, 30 October 2018.
Separately, Dr. Reddy's Laboratories announced during trading hours today, 31 October 2018, the launch of Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Strattera (atomoxetine) Capsules in the United States market approved by the US Food and Drug Administration (USFDA). The Strattera brand and generic had US sales of approximately $304 million MAT for the most recent twelve months ending in August 2018 according to IMS Health. Dr. Reddy's Atomoxetine Capsules, USP is available in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg with 30 counts bottle size. Straterra is a registered trademark of Eli Lilly and Company.
Meanwhile, the government has reportedly invoked never-before-used powers under the RBI Act allowing it to issue directions to the central bank governor on matters of public interest.
Media reports suggested that Section 7 of the RBI Act empowers the government to consult and give instructions to the governor to act on certain issues that the government considers serious and in public interest. This Section had never been used in independent India till now, reports added.
India's finance minister Arun Jaitley criticised the Reserve Bank of India (RBI) for failing to prevent lending excess in a speech on Tuesday, 30 October 2018. The central bank looked the other way when banks gave loans indiscriminately during 2008 to 2014, Jaitley reportedly said while speaking at an event in New Delhi. According to media reports, tensions between the finance ministry and the RBI have risen since the bank's deputy governor said in a speech on Friday that undermining a central bank's independence could be "potentially catastrophic", in an indication that it is pushing back hard against government pressure to relax its policies and reduce its powers.
Overseas, most stocks in Asia rose on Wednesday. Chinese official manufacturing Purchasing Managers' Index (PMI) was 50.2. The official manufacturing PMI had been 50.8 in September. China's official non-manufacturing purchasing managers index dropped to 53.9 from September's 54.9, the National Bureau of Statistics said on Wednesday. A reading above 50 indicates expansion, while a reading below that signals contraction.
US stocks closed higher Tuesday as President Donald Trump signaled that the US is ready to reach a deal to ease trade tensions with China, giving the market some much-needed relief. Markets were also digesting a raft of quarterly corporate results with several big-name companies set to report earnings this week.
On the US data front, home-price gains are slowing, as the Case-Shiller 10-city composite index showed a 0.6% increase from last month's reading, or a 5.5% annual increase. The 20-city composite index rose a seasonally adjusted 0.1% and was 5.5% higher compared to its level a year ago, the lowest annual increase in nearly two years.
Consumer sentiment hit an 18-year high, according to the Conference Board's consumer confidence index, which rose to 137.9, from 135.3 in September.
The residential vacancy rate fell 0.4% points from a year earlier to 7.1%, according to the Census Bureau report, which also showed that the US homeownership rate was virtually unchanged at 64.4%.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content